TNF-α as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS)

Journal of Dermatological Science

Volumn 74, Issue 2, 2014, Pages 177-179

  Uno, Hirokazu ^a   Kabashima, Kenji ^b   Tohyama, Mikiko ^c   Watanabe, Tsunamasa ^d   Hashimoto, Koji ^c   Iijima, Masafumi ^a   Sueki, Hirohiko ^a   Watanabe, Hideaki ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOPURINOL; C REACTIVE PROTEIN; CARBAMAZEPINE; CREATININE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MEXILETINE; PHENOBARBITAL; PHENYTOIN; SALAZOSULFAPYRIDINE; TRICHLOROETHYLENE; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADULT; AGED; ANTIBODY TITER; CLINICAL ARTICLE; CONTROLLED STUDY; DRESS SYNDROME; EOSINOPHILIA; ERYTHEMA MULTIFORME; ERYTHRODERMA; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; JAPAN; LETTER; LEUKOCYTOSIS; LYMPHOCYTOSIS; MACULOPAPULAR RASH; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; VERY ELDERLY; VIRUS REACTIVATION; BLOOD; COMPLICATION; EXANTHEMA SUBITUM; VIROLOGY;

ADULT; AGED; BIOLOGICAL MARKERS; DRUG HYPERSENSITIVITY SYNDROME; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; MALE; MIDDLE AGED; ROSEOLOVIRUS INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897115937     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.01.007     Document Type: Letter

References (10)

1. Tohyama M., Hashimto K. New aspects of drug-induced hypersensitivity syndrome. J Dermatol 2011, 38:222-228.
2. Bocquet H., Bagot M., Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996, 15:250-257.
3. Kardaun S.H., Sekula P., Valeyrie-Allanore L., Liss Y., Chu C.Y., Creamer D., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013, 169:1071-1080.
4. Wei C.H., Chung-Yee Hui R., Chang C.J., Ho H.C., Yang C.H., Lin Y.J., et al. Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS). Eur J Dermatol 2011, 21:930-937.
5. Bastuji-Garin S., Rzany B., Stern R.S., Shear N.H., Naldi L., Roujeau J.C. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993, 129:92-96.
6. Watanabe R., Watanabe H., Sotozono C., Kokaze A., Iijima M. Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). Eur J Dermatol 2011, 21:889-894.
7. Watanabe H., Tohyama M., Kamijima M., Nakajima T., Yoshida T., Hashimoto K., et al. Occupational trichloroethylene hypersensitivity syndrome with human herpesvirus-6 and cytomegalovirus reactivation. Dermatology 2010, 221:17-22.
8. Tong C.Y., Bakran A., Williams H., Cuevas L.E., Peiris J.S., Hart C.A. Association of tumour necrosis factor alpha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation. J Med Virol 2001, 64:29-34.
9. Yoshikawa T., Fujita A., Yagami A., Suzuki K., Matsunaga K., Ihira M., et al. Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome. J Clin Virol 2006, 37(Suppl. 1):S92-S96.
10. Kamijima M., Wang H., Yamanoshita O., Ito Y., Xia L., Yanagiba Y., et al. Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes. J Dermatol Science 2013, 72:218-224.